The impact of learning‐curve‐experience on transcatheter aortic valve replacement outcomes: Insights from the United Kingdom and Ireland all‐comers second‐generation ACURATE neo™ transcatheter aortic heart valve registry

The ACURATE neo™ is a novel, second-generation self-expanding supra-annular transcatheter heart valve (THV). The objective of this multi-centre registry is to assess the safety, clinical utility, and impact of 'learning-curve-experience' (LCE) on transcatheter aortic valve replacement outcomes in the United Kingdom (UK) and Ireland.We prospectively collected data from seven ACURATE neo™ THV implanting centres (n = 484) between February 2016 and...